Noelia Vilariño

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes et al. · The Lancet Respiratory Medicine · 2018 · 222 citations · Full text

Medicine, Oncology, Epigenetics +16

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

Ernest Nadal, Delvys Rodríguez‐Abreu, Marta Simó et al. · Journal of Clinical Oncology · 2023 · 106 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Form of Apolipoprotein A-I Is Found Specifically in Relapses of Focal Segmental Glomerulosclerosis Following Transplantation

Joan López-Hellín, C. Cantarell, Luisa Jimeno et al. · American Journal of Transplantation · 2012 · 60 citations

Medicine, Nephrology, Pathology +14

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series

Carla Marco, Marta Simó, Montse Alemany et al. · Journal of Clinical Medicine · 2022 · 31 citations · Full text

Life Sciences, Immunology, Oncology +17

Updated analysis from the ATEZO-BRAIN trial: Atezolizumab plus carboplatin and pemetrexed in patients with advanced nonsquamous non–small cell lung cancer with untreated brain metastases.

Ernest Nadal, Delvys Rodríguez‐Abreu, Bartomeu Massutí et al. · Journal of Clinical Oncology · 2022 · 24 citations

Medicine, Oncology, Pharmacotherapy +16